Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including... see more

TSX:CURA - Post Discussion

Curaleaf Holdings Inc > UK medical cannabis patient numbers could surge in 2023
View:
Post by blackspade799 on Apr 05, 2023 5:44pm

UK medical cannabis patient numbers could surge in 2023

''analysts predict that patient numbers will hit over 47,000 by the end of the year.

While there is no official data on the exact number of patients currently prescribed cannabis in the UK, experts believe the figure to be around 25,000-30,000, with more than 20 clinics prescribing the treatment privately. ''

'' analysts calculate that the annual number of products prescribed during 2022 amounts to around 76,600, a 90% increase from the year before.'' 


''The report, which examines the outlook of the European medical cannabis industry, says demand continues to rise across the continent with sales projected to reach over €550 million by the end of 2023.''

https://cannabishealthnews.co.uk/2023/03/30/uk-medical-cannabis-patient-numbers-surge-in-2023/

Comment by Bullknit101 on Apr 05, 2023 10:00pm
Curaleaf is the only MSO with a European presence. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities